1,794
Views
21
CrossRef citations to date
0
Altmetric
Research Papers

Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers

, , , , , , , & show all
Pages 1528-1535 | Received 10 Sep 2015, Accepted 05 Nov 2015, Published online: 11 Mar 2016

References

  • ACIP Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Moral Wkly Rep 2007:56. http://origin.glb.cdc.gov.ezproxy.bu.edu/MMWR/preview/mmwrhtml/rr5602a1.htm. Accessed September 15, 2014
  • ACIP. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-9; PMID:2050859s3
  • Joura EA, Giuliano AR, Iversen OE, Bouchard C, Mao C, Mehlsen J, Moreira ED, Jr, Ngan Y, Petersen LK, Lazcano-Ponce E, et al. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. N Engl J Med 2015; 372(8):711-23; PMID:25693011; http://dx.doi.org/10.1056/NEJMoa1405044
  • Markowitz LE, Hariri S, Lin C, Dunne EF, Steinau M, McQuillan G, Unger ER. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010. J Infect Dis 2013; 208(3):385-93; PMID:23785124; http://dx.doi.org/10.1093/infdis/jit192
  • Niccolai LM, Julian PJ, Meek JI, McBride V, Hadler JL, Sosa LE. Declining rates of high-grade cervical lesions in young women in Connecticut, 2008–2011. Cancer Epidemiol Biomarkers Prev 2013; 22(8):1446-50; PMID:23704476; http://dx.doi.org/10.1158/1055-9965.EPI-13-0272
  • Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RC, Markowitz L. Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 - United States. MMWR Morb Mortal Wkly Rep 2014; 63(29):620-4. http://www.ncbi.nlm.nih.gov/pubmed/25055185; PMID:25055185
  • Gertig DM, Brotherton JML, Budd AC, Drennan K, Chappell G, Saville AM. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 2013; 11:227; PMID:24148310; http://dx.doi.org/10.1186/1741-7015-11-227
  • Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. JAMA 2014; 311(6):597-603; PMID:24519299; http://dx.doi.org/10.1001/jama.2014.95
  • Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374(9686):301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4
  • Group F. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356(19):1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741
  • Pomfret TC, Gagnon JM, Gilchrist AT. Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 2011; 36(1):1-9; PMID:21198715; http://dx.doi.org/10.1111/j.1365-2710.2009.01150.x
  • SEER Stat Fact Sheets: Cervix Uteri Cancer. http://seer.cancer.gov/statfacts/html/cervix.html. Published 2013
  • Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, Mallison C. Factors Associated With Initiation and Completion of Human papillomavirus vaccine series among young women enrolled in medicaid. J Adolesc Heal 2010; 47(6):596-9; http://dx.doi.org/10.1016/j.jadohealth.2010.09.015
  • Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011; 127(1):77-84; PMID:21149425; http://dx.doi.org/10.1542/peds.2010-0812
  • Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination. Matern Child Health J 2013; 17(5):879-85; PMID:22729660; http://dx.doi.org/10.1007/s10995-012-1066-z
  • Kouyoumdjian FG, Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J 2011; 30(8):718-9; PMID:21343841; http://dx.doi.org/10.1097/INF.0b013e3182121426
  • Alexander AB, Stupiansky NW, Ott MA, Herbenick D, Reece M, Zimet GD. Parent-son decision-making about human papillomavirus vaccination: a qualitative analysis. BMC Pediatr 2012; 12(1):192; PMID:23241217
  • Alexander AB, Best C, Stupiansky N, Zimet GD. A model of health care provider decision making about HPV vaccination in adolescent males. Vaccine 2015; 33(33):4081-6; PMID:26143612
  • Bordley C, Vann JC, Chelminski A, Kraus RM, Margolis PA. Effect of Patient Reminder / Recall Interventions on Immunization Rates A Review. J Am Med Assoc 2014; 284(14):1820-7
  • Cassidy B, Braxter B, Charron-Prochownik D, Schlenk EA. A quality improvement initiative to increase HPV vaccine rates using an educational and reminder strategy with parents of preteen girls. J Pediatr Health Care 2014; 28(2):155-64; PMID:23522561
  • Chao C, Preciado M, Slezak J, Xu L. A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health 2015; 56(1):85-90; PMID:25438965
  • Kharbanda EO, Stockwell MS, Fox HW, Andres R, Lara M, Rickert VI. Text message reminders to promote human papillomavirus vaccination. Vaccine 2011; 29(14):2537-41; PMID:21300094
  • Matheson EC, Derouin A, Gagliano M, Thompson JA, Blood-Siegfried J. Increasing HPV Vaccination Series Completion Rates via Text Message Reminders. J Pediatr Health Care 2014; 28(4):e35-9; PMID:24200295
  • Stockwell MS, Kharbanda EO, Martinez RA, Lara M, Vawdrey D, Natarajan K, Rickert VI. Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations. Am J Public Health 2012; 102(2):e15-21; PMID:22390457
  • Groom H, Hopkins DP, Pabst LJ, Murphy Morgan J, Patel M, Calonge N, Coyle R, Dombkowski K, Groom AV, et al. Immunization Information Systems to Increase Vaccination Rates: A Community Guide Systematic Review. J Public Health Manag Pract 2014; 97227:1-22
  • Kempe A, Saville AW, Dickinson LM, Beaty B, Eisert S, Gurfinkel D, Brewer S, Shull H, Herrero D, Herlihy R. Collaborative centralized reminder/recall notification to increase immunization rates among young children: a comparative effectiveness trial. JAMA Pediatr 2015; 169(4):365-73; PMID:25706340
  • Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007; 161:252-9; PMID:17339506
  • Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, Kahn JA. Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination. J Women's Heal 2009; 18(10):1679-86
  • Ferrer HB, Trotter C, Hickman M, Audrey S. Barriers and facilitators to HPV vaccination of young women in high-income countries: a qualitative systematic review and evidence synthesis. BMC Public Health 2014; 14(1):700; PMID:25004868
  • Pourat N, Jones JM. Role of Insurance, Income, and Affordability in Human Papillomavirus Vaccination. Am J Manag Care 2012; 18(6):320-30; PMID:22775000
  • Rambout L, Tashkandi M, Hopkins L, Tricco AC. Self-reported barriers and facilitators to preventive human papillomavirus vaccination among adolescent girls and young women: a systematic review. Prev Med (Baltim) 2014; 58:22-32
  • Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics 2008; 122(4):718-25; PMID:18829793; http://dx.doi.org/10.1542/peds.2007-0538
  • Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics 2013; 132(6):1037-46; PMID:24190677; http://dx.doi.org/10.1542/peds.2013-2037
  • Fredrickson DD, Davis TC, Arnold CL, Kennen EM, Hurniston SG, Cross JT, Bocchini JA, Jr. Childhood Immunization Refusal: Provider and Parent Perceptions. Fam Med 2004; 36(6):431-9; PMID:15181556
  • Healy CM, Pickering LK. How to communicate with vaccine-hesitant parents. Pediatrics 2011; 127 Suppl (May 2011):S127-33; PMID:21502238; http://dx.doi.org/10.1542/peds.2010-1722S
  • Smith PJ, Kennedy AM, Wooten K, Gust DA, Pickering LK. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage. Pediatrics 2006; 118(5):e1287-92; PMID:17079529; http://dx.doi.org/10.1542/peds.2006-0923
  • Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, Rosenquist AW, Pierre-Joseph N. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics 2014; 134(3):e666-74; PMID:25136036; http://dx.doi.org/10.1542/peds.2014-0442

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.